F2RL1 and hepatocellular carcinoma: This has been demonstrated very recently in human hepatocellular carcinoma cells for which suppression of CD47 by a morpholino approach exerted a chemosensitization effect through blockade of cathepsin S/protease-activated receptor 2 (PAR2) signaling (Lee et al., 2014).